SRB Corp Has $673,000 Position in AmerisourceBergen Corp. (NYSE:ABC)
SRB Corp raised its position in AmerisourceBergen Corp. (NYSE:ABC) by 34.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,472 shares of the company’s stock after purchasing an additional 2,187 shares during the period. SRB Corp’s holdings in AmerisourceBergen were worth $673,000 as of its most recent filing with the SEC.
Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc raised its position in AmerisourceBergen by 0.4% in the third quarter. Vanguard Group Inc now owns 16,019,657 shares of the company’s stock valued at $1,477,332,000 after purchasing an additional 63,935 shares during the period. Dupont Capital Management Corp lifted its holdings in shares of AmerisourceBergen by 45.3% in the 4th quarter. Dupont Capital Management Corp now owns 2,439 shares of the company’s stock valued at $181,000 after purchasing an additional 760 shares during the last quarter. Pinnacle Associates Ltd. raised its stake in AmerisourceBergen by 9.5% during the 4th quarter. Pinnacle Associates Ltd. now owns 5,915 shares of the company’s stock valued at $440,000 after acquiring an additional 515 shares during the last quarter. Oregon Public Employees Retirement Fund increased its position in AmerisourceBergen by 6,614.4% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,448,589 shares of the company’s stock worth $46,000 after purchasing an additional 3,397,228 shares during the period. Finally, Clarus Wealth Advisors increased its position in AmerisourceBergen by 12.2% during the 4th quarter. Clarus Wealth Advisors now owns 1,308 shares of the company’s stock worth $97,000 after purchasing an additional 142 shares during the period. 66.56% of the stock is owned by institutional investors.
In other AmerisourceBergen news, Director Richard W. Gochnauer sold 5,500 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $80.69, for a total value of $443,795.00. Following the sale, the director now directly owns 12,364 shares of the company’s stock, valued at $997,651.16. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert P. Mauch sold 24,767 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $81.16, for a total value of $2,010,089.72. Following the completion of the sale, the executive vice president now directly owns 43,286 shares in the company, valued at $3,513,091.76. The disclosure for this sale can be found here. Insiders have sold a total of 51,563 shares of company stock worth $4,164,135 in the last 90 days. 27.80% of the stock is currently owned by insiders.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Thursday, May 2nd. The company reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.96 by $0.15. The business had revenue of $43.32 billion for the quarter, compared to analysts’ expectations of $43.44 billion. AmerisourceBergen had a net margin of 0.53% and a return on equity of 46.24%. The firm’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.94 earnings per share. As a group, equities research analysts anticipate that AmerisourceBergen Corp. will post 6.84 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 3rd. Stockholders of record on Monday, May 20th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 1.85%. AmerisourceBergen’s dividend payout ratio (DPR) is 24.65%.
ABC has been the topic of a number of recent analyst reports. TheStreet raised AmerisourceBergen from a “c+” rating to a “b” rating in a research note on Tuesday, February 19th. Zacks Investment Research upgraded AmerisourceBergen from a “hold” rating to a “buy” rating and set a $89.00 price target for the company in a research note on Wednesday. ValuEngine cut shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Monday, February 25th. Argus dropped their target price on AmerisourceBergen from $115.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, June 3rd. Finally, Bank of America lowered shares of AmerisourceBergen from a “buy” rating to an “underperform” rating and decreased their price target for the stock from $95.00 to $76.00 in a research report on Wednesday, April 10th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $88.33.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
See Also: Street Name
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.